Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Société Générale M&A Activity 2021

Apr 12, 2021

1671_mrq_2021-04-12_34d21984-0289-49c6-9080-0d66c39fa9e5.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 1548V

Societe Generale SA

12 April 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1) Société Générale S.A.
Company dealt in Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2) US$0.000304635 ordinary shares
Date of dealing 09/04/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long Short
Number (%) Number (%)
(1) Relevant securities 883,683 0.69 1,238 0.00
(2) Derivatives (other than options) 1,136 0.00 587,906 0.46
(3) Options and agreements to purchase/sell 0 0.00 0 0.00
Total *1,768,305 *1.37 589,144 0.46

* Include the holding of shares 883,486 on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale Number of relevant securities Price per unit USD (Note 5)
Purchase 16 237.66
Purchase 100 238.38
Purchase 100 239.59
Purchase 38 237.66
Purchase 193 237.66
Purchase 76 237.66
Purchase 38 237.66
Purchase 192 239.98
Purchase 9 238.81
Purchase 9 239.52
Purchase 10 239.6
Purchase 10 239.52
Purchase 1 239.142
Purchase 1 237.662
Purchase 1 239.042
Purchase 1 237.902
Purchase 1 239.242
Purchase 1 239.102
Purchase 1 238.382
Purchase 1 239.652
Purchase 1 239.592
Purchase 1 237.302
Purchase 1 239.612
Purchase 1 238.122
Purchase 1 239.322
Purchase 1 239.612
Purchase 1 238.612
Purchase 1 239.162
Purchase 1 237.662
Purchase 1 238.782
Purchase 1 238.822
Purchase 1 237.072
Purchase 1 238.922
Purchase 1 238.402
Purchase 1 238.822
Purchase 1 237.992
Purchase 1 238.382
Purchase 1 239.092
Purchase 1 238.092
Purchase 1 239.032
Purchase 1 238.782
Purchase 1 236.822
Purchase 1 239.362
Purchase 1 238.872
Purchase 1 239.352
Purchase 836 239.98
Purchase 684 239.98
Sale 100 238.54
Sale 74 239.08
Sale 26 239.08
Sale 1,130 239.98
Sale 100 238.39
Sale 40 238.79
Sale 40 238.79
Sale 20 238.79
Total Purchases 2,344
Total Sales 1,530

Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit USD

(Note 5)
Euro Medium Term Note Increased long 1 112.5737

(b)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(c)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any 

other person relating to the voting rights of any relevant securities under any option referred to on this 

form or relating to the voting rights or future acquisition or disposal of any relevant securities to which 

any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure 12/04/2021
Contact name Société Générale - Disclosure team
Telephone number +33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEFLFLISAIFLIL